Literature DB >> 24582311

Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts.

William T Shearer1, Thomas A Fleisher2, Rebecca H Buckley3, Zuhair Ballas4, Mark Ballow5, R Michael Blaese6, Francisco A Bonilla7, Mary Ellen Conley8, Charlotte Cunningham-Rundles9, Alexandra H Filipovich10, Ramsay Fuleihan11, Erwin W Gelfand12, Vivian Hernandez-Trujillo13, Steven M Holland14, Richard Hong15, Howard M Lederman16, Harry L Malech14, Stephen Miles17, Luigi D Notarangelo7, Hans D Ochs18, Jordan S Orange19, Jennifer M Puck20, John M Routes21, E Richard Stiehm22, Kathleen Sullivan23, Troy Torgerson18, Jerry Winkelstein16.   

Abstract

The present uncertainty of which live viral or bacterial vaccines can be given to immunodeficient patients and the growing neglect of societal adherence to routine immunizations has prompted the Medical Advisory Committee of the Immune Deficiency Foundation to issue recommendations based on published literature and the collective experience of the committee members. These recommendations address the concern for immunodeficient patients acquiring infections from healthy subjects who have not been immunized or who are shedding live vaccine-derived viral or bacterial organisms. Such transmission of infectious agents can occur within the hospital, clinic, or home or at any public gathering. Collectively, we define this type of transmission as close-contact spread of infectious disease that is particularly relevant in patients with impaired immunity who might have an infection when exposed to subjects carrying vaccine-preventable infectious diseases or who have recently received a live vaccine. Immunodeficient patients who have received therapeutic hematopoietic stem transplantation are also at risk during the time when immune reconstitution is incomplete or while they are receiving immunosuppressive agents to prevent or treat graft-versus-host disease. This review recommends the general education of what is known about vaccine-preventable or vaccine-derived diseases being spread to immunodeficient patients at risk for close-contact spread of infection and describes the relative risks for a child with severe immunodeficiency. The review also recommends a balance between the need to protect vulnerable subjects and their social needs to integrate into society, attend school, and benefit from peer education. Published by Mosby, Inc.

Entities:  

Keywords:  Live viral and bacterial vaccines; cellular immune reconstitution; primary immunodeficiency disease; severe combined immunodeficiency disease

Mesh:

Substances:

Year:  2014        PMID: 24582311      PMCID: PMC4009347          DOI: 10.1016/j.jaci.2013.11.043

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

1.  Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome.

Authors:  Nashat Al-Sukaiti; Brenda Reid; Sasson Lavi; Daifulah Al-Zaharani; Adelle Atkinson; Chaim M Roifman; Eyal Grunebaum
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

2.  Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS).

Authors:  Nyasha Bakare; David Menschik; Rosemary Tiernan; Wei Hua; David Martin
Journal:  Vaccine       Date:  2010-07-30       Impact factor: 3.641

3.  Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia.

Authors:  C M Wilfert; R H Buckley; T Mohanakumar; J F Griffith; S L Katz; J K Whisnant; P A Eggleston; M Moore; E Treadwell; M N Oxman; F S Rosen
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

4.  Prevention of poliomyelitis: recommendations for use of only inactivated poliovirus vaccine for routine immunization. Committee on Infectious Diseases. American Academy of Pediatrics.

Authors: 
Journal:  Pediatrics       Date:  1999-12       Impact factor: 7.124

5.  Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine.

Authors:  Alexander E Platonov; Irina V Vershinina; Edward J Kuijper; Ray Borrow; Helena Käyhty
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641

6.  Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota.

Authors:  James P Alexander; Kristen Ehresmann; Jane Seward; Gary Wax; Kathleen Harriman; Susan Fuller; Elizabeth A Cebelinski; Qi Chen; Jaume Jorba; Olen M Kew; Mark A Pallansch; M Steven Oberste; Mark Schleiss; Jeffrey P Davis; Bryna Warshawsky; Susan Squires; Harry F Hull
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

7.  Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man.

Authors:  Calman MacLennan; Glynis Dunn; Aarnoud P Huissoon; Dinakantha S Kumararatne; Javier Martin; Paula O'Leary; Ronald A Thompson; Husam Osman; Philip Wood; Philip Minor; David J Wood; Deenan Pillay
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

8.  Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies.

Authors:  Penny Titman; Elizabeth Pink; Emily Skucek; Katherine O'Hanlon; Tim J Cole; Jane Gaspar; Jinhua Xu-Bayford; Alison Jones; Adrian J Thrasher; E Graham Davies; Paul A Veys; H Bobby Gaspar
Journal:  Blood       Date:  2008-07-21       Impact factor: 22.113

9.  Immunodeficiency-associated vaccine-derived poliovirus type 3 in infant, South Africa, 2011.

Authors:  Nicksy Gumede; Vongani Muthambi; Barry D Schoub
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

10.  Long-term neurocognitive function of pediatric patients with severe combined immune deficiency (SCID): pre- and post-hematopoietic stem cell transplant (HSCT).

Authors:  Malinda Lin; Karen Epport; Colleen Azen; Robertson Parkman; Donald B Kohn; Ami J Shah
Journal:  J Clin Immunol       Date:  2008-09-20       Impact factor: 8.317

View more
  49 in total

1.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

Review 2.  History and current status of newborn screening for severe combined immunodeficiency.

Authors:  Antonia Kwan; Jennifer M Puck
Journal:  Semin Perinatol       Date:  2015-04-30       Impact factor: 3.300

Review 3.  Immunization of children with secondary immunodeficiency.

Authors:  Susanna Esposito; Elisabetta Prada; Mara Lelii; Luca Castellazzi
Journal:  Hum Vaccin Immunother       Date:  2015-07-15       Impact factor: 3.452

Review 4.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

Review 5.  Immune-mediated adverse reactions to vaccines.

Authors:  Cosby A Stone; Christine R F Rukasin; Thomas M Beachkofsky; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2019-11-05       Impact factor: 4.335

Review 6.  Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

Authors:  Jennifer Heimall; Rebecca H Buckley; Jennifer Puck; Thomas A Fleisher; Andrew R Gennery; Elie Haddad; Benedicte Neven; Mary Slatter; Skinner Roderick; K Scott Baker; Andrew C Dietz; Christine Duncan; Linda M Griffith; Luigi Notarangelo; Michael A Pulsipher; Morton J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-04       Impact factor: 5.742

Review 7.  Vaccination in patients with immunosuppression.

Authors:  Ahmet Arvas
Journal:  Turk Pediatri Ars       Date:  2014-09-01

Review 8.  Application of Flow Cytometry in the Evaluation of Primary Immunodeficiencies.

Authors:  Thomas A Fleisher; Manisha Madkaikar; Sergio D Rosenzweig
Journal:  Indian J Pediatr       Date:  2016-02-11       Impact factor: 1.967

9.  Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.

Authors:  Antonia Kwan; Roshini S Abraham; Robert Currier; Amy Brower; Karen Andruszewski; Jordan K Abbott; Mei Baker; Mark Ballow; Louis E Bartoshesky; Francisco A Bonilla; Charles Brokopp; Edward Brooks; Michele Caggana; Jocelyn Celestin; Joseph A Church; Anne Marie Comeau; James A Connelly; Morton J Cowan; Charlotte Cunningham-Rundles; Trivikram Dasu; Nina Dave; Maria T De La Morena; Ulrich Duffner; Chin-To Fong; Lisa Forbes; Debra Freedenberg; Erwin W Gelfand; Jaime E Hale; I Celine Hanson; Beverly N Hay; Diana Hu; Anthony Infante; Daisy Johnson; Neena Kapoor; Denise M Kay; Donald B Kohn; Rachel Lee; Heather Lehman; Zhili Lin; Fred Lorey; Aly Abdel-Mageed; Adrienne Manning; Sean McGhee; Theodore B Moore; Stanley J Naides; Luigi D Notarangelo; Jordan S Orange; Sung-Yun Pai; Matthew Porteus; Ray Rodriguez; Neil Romberg; John Routes; Mary Ruehle; Arye Rubenstein; Carlos A Saavedra-Matiz; Ginger Scott; Patricia M Scott; Elizabeth Secord; Christine Seroogy; William T Shearer; Subhadra Siegel; Stacy K Silvers; E Richard Stiehm; Robert W Sugerman; John L Sullivan; Susan Tanksley; Millard L Tierce; James Verbsky; Beth Vogel; Rosalyn Walker; Kelly Walkovich; Jolan E Walter; Richard L Wasserman; Michael S Watson; Geoffrey A Weinberg; Leonard B Weiner; Heather Wood; Anne B Yates; Jennifer M Puck; Vincent R Bonagura
Journal:  JAMA       Date:  2014-08-20       Impact factor: 56.272

10.  An attenuated virus vaccine appears safe to the central nervous system of rainbow trout (Oncorhynchus mykiss) after intranasal delivery.

Authors:  Erin T Larragoite; Luca Tacchi; Scott E LaPatra; Irene Salinas
Journal:  Fish Shellfish Immunol       Date:  2016-01-06       Impact factor: 4.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.